drugset / Trial / NCT03336437
Estrogen and the Urogenital Microbiome in GSM
RandomizedParallel-groupSingle-blindBasic science
Summary
This is a study of how local estrogen treatment affects the microbiome of the vagina and bladder in postmenopausal women experiencing symptoms as part of "Genitourinary Syndrome of Menopause." The goal is to understand more about the underlying microbial changes occurring in menopause and whether these are reversible with estrogen.
Timeline
- Start
- 2018-02-01
- Primary completion
- 2019-08-23
- Completion
- 2019-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 2 mg | Other |
Indications
No indication recorded.